Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 567

1.

Role of angiogenesis in tumor growth and metastasis.

Folkman J.

Semin Oncol. 2002 Dec;29(6 Suppl 16):15-8. Review.

PMID:
12516034
2.

[Angiogenesis and antiangiogenic cancer therapy].

Pour L, Hájek R, Buchler T, Maisnar V, Smolej L.

Vnitr Lek. 2004 Dec;50(12):930-8. Review. Czech.

PMID:
15717808
3.

[The clinical perspective of angiogenesis inhibitors].

Radema SA, Witteveen PO, Gebbink MB, Voest EE.

Ned Tijdschr Geneeskd. 2003 Aug 30;147(35):1675-80. Review. Dutch.

PMID:
14513538
4.

Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy.

Dell'Eva R, Pfeffer U, Indraccolo S, Albini A, Noonan D.

Endothelium. 2002;9(1):3-10. Review.

PMID:
12901356
5.

Angiostatin and endostatin: endogenous inhibitors of tumor growth.

Sim BK, MacDonald NJ, Gubish ER.

Cancer Metastasis Rev. 2000;19(1-2):181-90. Review.

PMID:
11191058
6.

Endostatin: a promising drug for antiangiogenic therapy.

Cirri L, Donnini S, Morbidelli L, Chiarugi P, Ziche M, Ledda F.

Int J Biol Markers. 1999 Oct-Dec;14(4):263-7. Review.

PMID:
10669957
7.

Angiogenesis and cancer: recent advances.

Cáceres W, González S.

P R Health Sci J. 2003 Jun;22(2):149-51. Review.

PMID:
12866139
8.

[Tumor angiogenesis inhibitors: media and scientific aspects].

Raymond E.

Presse Med. 1998 Jul 4-11;27(24):1221-4. Review. French.

PMID:
9767782
9.

Angiogenesis and tumor metastasis.

Zetter BR.

Annu Rev Med. 1998;49:407-24. Review.

PMID:
9509272
10.

[Antiangiogenic therapy].

Toi M.

Gan To Kagaku Ryoho. 1998 Nov;25(13):2003-9. Review. Japanese.

PMID:
9838900
11.

Molecular mechanisms of tumor angiogenesis and tumor progression.

Cavallaro U, Christofori G.

J Neurooncol. 2000 Oct-Nov;50(1-2):63-70. Review.

PMID:
11245282
12.
13.

Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.

Scappaticci FA, Smith R, Pathak A, Schloss D, Lum B, Cao Y, Johnson F, Engleman EG, Nolan GP.

Mol Ther. 2001 Feb;3(2):186-96.

14.

Regulating angiogenesis: a new therapeutic strategy.

Gibaldi M.

J Clin Pharmacol. 1998 Oct;38(10):898-903. Review.

PMID:
9807969
15.

Angiostatin.

Cao Y, Xue L.

Semin Thromb Hemost. 2004 Feb;30(1):83-93. Review.

PMID:
15034800
16.

Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.

Fernando NT, Koch M, Rothrock C, Gollogly LK, D'Amore PA, Ryeom S, Yoon SS.

Clin Cancer Res. 2008 Mar 1;14(5):1529-39. doi: 10.1158/1078-0432.CCR-07-4126.

17.

[Angiogenesis and bladder cancer: trendy prognostic factor or new therapeutic target?].

Jayet C, Deperthes D, Leisinger HJ.

Ann Urol (Paris). 2002 Jul;36(4):258-63. Review. French.

PMID:
12162191
18.
19.
20.

The promise of anti-angiogenic cancer therapy.

Oehler MK, Bicknell R.

Br J Cancer. 2000 Feb;82(4):749-52. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk